CD4 and lung adenocarcinoma: However, a significant increase of 1.4-fold to 1.75-fold was detected in the percentages of CD4+CD25+CD127−LAP TGF-β1+ Treg cells in lung adenocarcinoma patients compared with the corresponding population in the smoking and nonsmoking control groups.